Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) closed the day trading at $4.16 down -14.23% from the previous closing price of $4.85. In other words, the price has decreased by -$14.23 from its previous closing price. On the day, 0.66 million shares were traded. SONN stock price reached its highest trading level at $4.955 during the session, while it also had its lowest trading level at $4.1301.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SONN now has a Market Capitalization of 28401788 and an Enterprise Value of 27845644. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.45. Its current Enterprise Value per Revenue stands at 27.846 whereas that against EBITDA is -1.982.
Stock Price History:
The Beta on a monthly basis for SONN is 1.45, which has changed by 0.84410644 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, SONN has reached a high of $19.30, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -15.15%, while the 200-Day Moving Average is calculated to be 39.49%.
Shares Statistics:
Over the past 3-months, SONN traded about 910.24K shares per day on average, while over the past 10 days, SONN traded about 778420 shares per day. A total of 7.08M shares are outstanding, with a floating share count of 6.81M. Shares short for SONN as of 1763078400 were 2151547 with a Short Ratio of 2.78, compared to 1760486400 on 2184854. Therefore, it implies a Short% of Shares Outstanding of 2151547 and a Short% of Float of 31.56.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 1.0 analysts currently analyzing and rating the stock of Sonnet BioTherapeutics Holdings Inc (SONN). Analysts are recommending an EPS of between -$3.46 and -$3.46 for the fiscal current year, implying an average EPS of -$3.46.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for SONN’s current fiscal year. The highest revenue estimate was $1M, while the lowest revenue estimate was $1M, resulting in an average revenue estimate of $1M. In the same quarter a year ago, actual revenue was $18.63k
